Your browser doesn't support javascript.
loading
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019.
Grimm, Marc-Oliver; Bex, Axel; De Santis, Maria; Ljungberg, Börje; Catto, James W F; Rouprêt, Morgan; Hussain, Syed A; Bellmunt, Joaquim; Powles, Tom; Wirth, Manfred; Van Poppel, Hendrik.
Afiliación
  • Grimm MO; Department of Urology, Jena University Hospital, Jena, Germany. Electronic address: marc-oliver.grimm@med.uni-jena.de.
  • Bex A; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK; UCL Division of Surgery and Interventional Science, London, UK.
  • De Santis M; Department of Urology, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Urology, Medical University of Vienna, Austria.
  • Ljungberg B; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
  • Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Rouprêt M; Academic Department of Urology, Sorbonne Université, GRC no. 5, ONCOTYPE-URO, Hôpital Pitié-Salpêtrière, Assistance-Publique Hôpitaux de Paris, Paris, France.
  • Hussain SA; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK.
  • Bellmunt J; Harvard Medical School, Boston, MA, USA; Hospital del Mar Medical Research Institute, Barcelona, Spain.
  • Powles T; The Royal Free NHS Trust and Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Wirth M; Department of Urology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Van Poppel H; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Eur Urol ; 76(3): 368-380, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31235192
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Neoplasias Urológicas / Antineoplásicos Inmunológicos / Inmunoterapia Tipo de estudio: Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Transicionales / Neoplasias Urológicas / Antineoplásicos Inmunológicos / Inmunoterapia Tipo de estudio: Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article